Search
Taking a deep dive into atopic dermatitis with the CEO of Apogee Therapeutics
Michael Henderson describes the rationale behind Apogee's IL13 program and how it has been designed to have a longer half-life.
Dec 7, 2023
top of page
Search
Follow BiotechTV
Also look for unique social pages for BiotechTV U.
.png){kind=logo}
Sponsor Spotlight
Genezen is a contract development and manufacturing organization (CDMO) with unique technical expertise in lentiviral, retroviral, and adeno-associated viral vectors. Offering process development, GMP viral vector manufacturing, and analytics, we are dedicated to helping you deliver safe, pure, and potent advanced therapies to the patients who need them.
bottom of page